On the other hand, in children who received the mRNA anti-COVID-19 BNT162b2 parenteral vaccine, there is a slight increase in salivary Spike-specific IgA1, suggesting a different immune response to the vaccine compared to natural infection. This evidence concerns the gene IGHA1 and COVID-19.